145 related articles for article (PubMed ID: 9794249)
1. Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists.
Houston DB; Howlett AC
Cell Signal; 1998 Oct; 10(9):667-74. PubMed ID: 9794249
[TBL] [Abstract][Full Text] [Related]
2. Interaction of brain cannabinoid receptors with guanine nucleotide binding protein: a radioligand binding study.
Petitet F; Jeantaud B; Capet M; Doble A
Biochem Pharmacol; 1997 Dec; 54(11):1267-70. PubMed ID: 9416978
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
Ross RA; Brockie HC; Fernando SR; Saha B; Razdan RK; Pertwee RG
Br J Pharmacol; 1998 Nov; 125(6):1345-51. PubMed ID: 9863666
[TBL] [Abstract][Full Text] [Related]
4. Regional differences in cannabinoid receptor/G-protein coupling in rat brain.
Breivogel CS; Sim LJ; Childers SR
J Pharmacol Exp Ther; 1997 Sep; 282(3):1632-42. PubMed ID: 9316881
[TBL] [Abstract][Full Text] [Related]
5. Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange.
Kearn CS; Greenberg MJ; DiCamelli R; Kurzawa K; Hillard CJ
J Neurochem; 1999 Jun; 72(6):2379-87. PubMed ID: 10349847
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
Dhawan J; Deng H; Gatley SJ; Makriyannis A; Akinfeleye T; Bruneus M; Dimaio AA; Gifford AN
Synapse; 2006 Aug; 60(2):93-101. PubMed ID: 16715483
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
Breivogel CS; Griffin G; Di Marzo V; Martin BR
Mol Pharmacol; 2001 Jul; 60(1):155-63. PubMed ID: 11408610
[TBL] [Abstract][Full Text] [Related]
8. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
Ross RA; Brockie HC; Stevenson LA; Murphy VL; Templeton F; Makriyannis A; Pertwee RG
Br J Pharmacol; 1999 Feb; 126(3):665-72. PubMed ID: 10188977
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and pharmacological characterization of cannabinoid binding sites using [3H]SR141716A.
Petitet F; Marin L; Doble A
Neuroreport; 1996 Feb; 7(3):789-92. PubMed ID: 8733746
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum.
Griffin G; Wray EJ; Martin BR; Abood ME
Br J Pharmacol; 1999 Oct; 128(3):684-8. PubMed ID: 10516649
[TBL] [Abstract][Full Text] [Related]
11. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
Stark S; Pacheco MA; Childers SR
Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
[TBL] [Abstract][Full Text] [Related]
12. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
Darmani NA; Sim-Selley LJ; Martin BR; Janoyan JJ; Crim JL; Parekh B; Breivogel CS
Eur J Pharmacol; 2003 Jan; 459(1):83-95. PubMed ID: 12505537
[TBL] [Abstract][Full Text] [Related]
13. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
Yang ZM; Paria BC; Dey SK
Biol Reprod; 1996 Oct; 55(4):756-61. PubMed ID: 8879486
[TBL] [Abstract][Full Text] [Related]
14. Effects of cannabinoids on adrenaline release from adrenal medullary cells.
Niederhoffer N; Hansen HH; Fernandez-Ruiz JJ; Szabo B
Br J Pharmacol; 2001 Nov; 134(6):1319-27. PubMed ID: 11704653
[TBL] [Abstract][Full Text] [Related]
15. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ
Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515
[TBL] [Abstract][Full Text] [Related]
16. Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.
Niederhoffer N; Szabo B
Br J Pharmacol; 1999 Jan; 126(2):457-66. PubMed ID: 10077239
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum.
Devlin MG; Christopoulos A
J Neurochem; 2002 Mar; 80(6):1095-102. PubMed ID: 11953460
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids cause central sympathoexcitation and bradycardia in rabbits.
Niederhoffer N; Szabo B
J Pharmacol Exp Ther; 2000 Aug; 294(2):707-13. PubMed ID: 10900251
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.
Rinaldi-Carmona M; Barth F; Héaulme M; Alonso R; Shire D; Congy C; Soubrié P; Brelière JC; Le Fur G
Life Sci; 1995; 56(23-24):1941-7. PubMed ID: 7776817
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of the rat cerebella CB1 receptor using SR141716A, a central cannabinoid receptor antagonist.
Hirst RA; Almond SL; Lambert DG
Neurosci Lett; 1996 Dec; 220(2):101-4. PubMed ID: 8981483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
